Abstract:OBJECTIVE To compare the safety and efficacy of self-expandable stents (SES) and balloon-mounted stents (BMS) in the treatment of severe symptomatic intracranial vertebral artery atherosclerotic stenosis (SIVAAS). METHODS The clinical and imaging data of 76 consecutive cases who were stented for SIVAAS in our centers in ten years were reviewed retrospectively. The cases were divided into SES group and BMS group as per the type of stents. Conventional risk factors of atherosclerosis, the relationship between stenosis and the origin of posterior inferior cerebellar artery (PICA), whether the stenosis was located at the dural-entry zone of the vertebral artery (VA), the interventional access, periprocedural complications, and clinical and imaging follow-up results were analyzed statistically. RESULTS 77 stenotic lesions in 76 cases were included. Totally 51 SES and 26 BMS were implanted successfully. There was no significant difference in periprocedural complications (1 vs. 2, P = 0.544), incidence of restenosis (13.2% vs. 14.3%, P = 0.628) and long-term death or stroke (4 vs. 7, P = 0.33) between the two groups. The degree of residual stenosis in SES group was higher than in BMS group (10 (0%-40%) vs. 0 (0%-15%); P = 0). More BMS were selected in lesions located at the dural-entry zone of VA (45.1% vs. 73.1%, P = 0.02). There were more BMS implanted when lesions located proximal to origin of PICA (SES vs. BMS = 23.5% vs. 57.7%, P = 0.003) or when lesions with straighter access (SES vs. BMS = 29.4% vs. 69.2%, P = 0.001). More SES implanted when lesions located distal to PICA (SES vs. BMS = 43.1% vs. 15.4%, P = 0.015) or when lesions with moderate tortuous access (SES vs. BMS = 60.8% vs. 23.1%, P = 0.002). For stenotic lesions with moderate tortuous interventional access, SES group cases had longer survival time without stroke or death (P = 0.008). CONCLUSION Both SES and BMS showed high safety and efficacy for the treatment of SIVAAS. SES was more recommended for the stenotic lesions with tortuous interventional access. BMS was more recommended for the lesions located at the dural-entry zone of VA or proximal to PICA origin.

Abstract No. 599 Safety and Efficacy of Unilateral Balloon Expandable Covered Stent Graft Placement for Treatment of Malignant Superior Vena Cava Syndrome

Safety and Efficacy of Stent Graft Implantation for Malignant Superior Vena Cava Syndrome.

Safety and Efficacy of Stent Graft Implantation for Malignant Superior Vena

Safety and efficacy of large-bore uncovered stents for treating malignant superior vena cava syndrome

Safety and Effectiveness of Abre Self-Expanding Venous Stent for Treatment of Superior Vena Cava Syndrome

Results of Palliative Stenting in Malignant Superior Vena Cava Syndrome Analyzing Self-Expanding Stainless Steel and Nitinol Venous Bare Metal Stents

Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent.

Transcatheter stenting of superior vena cava to treat postoperative SVC syndrome in a child: a case report

Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions

[Progress on the Therapeutic Approaches for Malignant Tumor with Superior Vena Cava Syndrome].

Malignant Superior Vena Cava Syndrome: A Scoping Review

A Multicenter Retrospective Cohort Study on Superior Vena Cava Resection in Non-Small-Cell Lung Cancer Surgery.

Surgical treatment of superior vena cava syndrome:report of 13 cases

Combined interventional therapy for malignant vena cava obstruction

Comparison of self-expandable stents and balloon-mounted stents in the treatment of symptomatic intracranial vertebral artery atherosclerotic stenosis.

Diagnosis and Surgical Treatment of Superior Vena Cava Syndrome:Report of 27 Cases

Unilateral superior vena cava syndrome: An uncommon complication of a commonly used procedure

A Superior Squeeze: Superior Vena Cava Syndrome Secondary to Small Cell Lung Cancer

Newly Designed, Self-Expanding Large-Bore Nitinol Stents for Symptomatic Central Venous Stenosis: Technical and Long-Term Clinical Outcome

Surgical resection of an intraluminal tumor in the azygos vein with an unknown primary site causing superior vena cava syndrome

Unveiling a Unique Presentation of Superior Vena Cava Syndrome Succeeding a Traumatic Motor Vehicle Crash and Implantable Cardioverter-Defibrillator Lead Placement